The promise of Eli Lilly's weight-loss drug for sleep apnea adds reasons to own it
Eli Lilly's weight-loss drug Zepbound showed promise as a treatment for sleep apnea, giving investors more confidence to continue owning…
S&P 500 Index
It's not too late to buy Abbott stock after Friday's sell-off
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
News Coming to GE Healthcare (GEHC) Eliminates Excess Stock
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Here's Eli Lilly's Competitive Advantage in GLP-1 Obesity Drugs and Abbott's Supporting Role
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Gemstone Engagement Rings Capture Hearts and Market Share
Luxury precious rings in a row on display in a jewelry store in an upscale shopping mall. Craig Hastings |…
Why We Would Consider Buying More Eli Lilly Stock If It Were Down
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Wall Street changes its mind on these healthcare stocks. Why we were always optimistic
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Healthcare Portfolio Name Changes Fortunes Thanks to Management's AI Push
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
January was great for stocks: here are our five best-performing companies of the month
Benchmarks hit record highs as stocks advanced during a busy earnings season.
Fourth-quarter earnings set to be best of 2023
Traders work at the New York Stock Exchange (NYSE) in New York City, USA, on February 1, 2024. Brendan McDermid…